The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Transforming growth factor-β in myocardial disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wei, H., Bedja, D., Koitabashi, N., Xing, D., Chen, J., Fox-Talbot, K., Rouf, R., Chen, S., Steenbergen, C., Harmon, J. W., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202081109 · Cited by 132
RetractedSmad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Transforming Growth Factor-β Signaling in Immunity and Cancer
Batlle, E., & Massagué, J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.024 · Cited by 2,366
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
The progression from hypertension to congestive heart failure
Levy, D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530440037034 · Cited by 2,155
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
Research works printed but not linked: 19
- Wenzel, S. et al. TGF-β1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes. Basic Res. Cardiol. 105, 621–629 (2010). · doi:10.1007/s00395-010-0108-1
- Baxter, G. F., Mocanu, M. M., Brar, B. K., Latchman, D. S. & Yellon, D. M. Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK. J. Cardiovasc. Pharmacol. 38, 930–939 (2001). · DOI
- Kitamura, M., Suto, T., Yokoo, T., Shimizu, F. & Fine, L. G. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J. Immunol. 156, 2964–2971 (1996). · doi:10.4049/jimmunol.156.8.2964
- Dambrink, J. H. et al. Left ventricular dilatation and high-grade ventricular arrhythmias in the first year after myocardial infarction. CATS Investigators. Captopril and Thrombolysis Study. J. Card. Fail. 1, 3–11 (1994). · doi:10.1016/1071-9164(94)90003-5
- Lee, H. J., Lee, J. K., Miyake, S. & Kim, S. J. A novel E1A-like inhibitor of differentiation (EID) family member, EID-2, suppresses transforming growth factor (TGF)-β signaling by blocking TGF-β-induced formation of Smad3-Smad4 complexes. J. Biol. Chem. 279, 2666–2672 (2004). · doi:10.1074/jbc.m310591200
- Kumar, A. G. et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 95, 693–700 (1997). · doi:10.1161/01.cir.95.3.693
- Aziz, T. M., Burgess, M. I., Haselton, P. S., Yonan, N. A. & Hutchinson, I. V. Transforming growth factor β and diastolic left ventricular dysfunction after heart transplantation: echocardiographic and histologic evidence. J. Heart Lung Transpl. 22, 663–673 (2003). · doi:10.1016/s1053-2498(02)00657-5
- Boluyt, M. O., Bing, O. H. & Lakatta, E. G. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur. Heart J. 16 (Suppl. N), 19–30 (1995). · doi:10.1093/eurheartj/16.suppl_n.19
- Watkins, S. J., Borthwick, G. M., Oakenfull, R., Robson, A. & Arthur, H. M. Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent. Hypertens. Res. 35, 393–398 (2012). · doi:10.1038/hr.2011.196
- Wenzel, S., Muller, C., Piper, H. M. & Schluter, K. D. p38 MAP-kinase in cultured adult rat ventricular cardiomyocytes: expression and involvement in hypertrophic signalling. Eur. J. Heart Fail. 7, 453–460 (2005). · doi:10.1016/j.ejheart.2004.07.001
- Heger, J., Peters, S. C., Piper, H. M. & Euler, G. SMAD-proteins as a molecular switch from hypertrophy to apoptosis induction in adult ventricular cardiomyocytes. J. Cell Physiol. 220, 515–523 (2009). · doi:10.1002/jcp.21805
- Schneiders, D., Heger, J., Best, P., Michael Piper, H. & Taimor, G. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes. Cardiovasc. Res. 67, 87–96 (2005). · doi:10.1016/j.cardiores.2005.02.021
- Derangeon, M. et al. Transforming growth factor β receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease. Cardiovasc. Res. 113, 464–474 (2017). · doi:10.1093/cvr/cvx026
- Li, G. et al. Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism. Circulation 98, II144–II149 (1998). discussion II149-150.
- Pino-Marin, A. et al. Chagas cardiomyopathy: from Romaña sign to heart failure and sudden cardiac death. Pathogens 10, 505 (2021). · doi:10.3390/pathogens10050505
- Cruz, J. S., Machado, F. S., Ropert, C. & Roman-Campos, D. Molecular mechanisms of cardiac electromechanical remodeling during Chagas disease: role of TNF and TGF-β. Trends Cardiovasc. Med. 27, 81–91 (2017). · doi:10.1016/j.tcm.2016.08.003
- Samudio, M. et al. Local and systemic cytokine expression during experimental chronic Trypanosoma cruzi infection in a Cebus monkey model. Parasite Immunol. 21, 451–460 (1999). · doi:10.1046/j.1365-3024.1999.00242.x
- Stauber, A. J., Credille, K. M., Truex, L. L., Ehlhardt, W. J. & Young, J. K. Nonclinical safety evaluation of a transforming growth factor β receptor I kinase inhibitor in Fischer 344 rats and beagle dogs. J. Clin. Pract. 4, 1000196 (2014).
- Chen, H., Li, D., Saldeen, T. & Mehta, J. L. TGF-β1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am. J. Physiol. Heart Circ. Physiol. 284, H1612–H1617 (2003). · doi:10.1152/ajpheart.00992.2002
Cited by
Chromatin remodelling drives immune cell–fibroblast communication in heart failure
Alexanian, M., Padmanabhan, A., Nishino, T., Travers, J. G., Ye, L., Pelonero, A., Lee, C. Y., Sadagopan, N., Huang, Y., Auclair, K., et al. (2024) · Nature · doi:10.1038/s41586-024-08085-6 · Cited by 140
Li, R., & Frangogiannis, N. G. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.07.006 · Cited by 62
Self-citationNew Mechanical Markers for Tracking the Progression of Myocardial Infarction
Chang, Z., Zhang, J., Liu, Y., Gao, H., & Xu, G.-K. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c01712 · Cited by 35
Metadata
- Authors
- Frangogiannis, N. G.
- Venue
- Nature Reviews Cardiology
- Published
- 2022-01-04
- Volume
- 19
- Issue
- 7
- Pages
- 435-455
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W4205403685
- Cited by
- 344
- References
- 296
- FWCI
- 19.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transforming growth factor-β in myocardial disease. https://app.cochat.ai/papers/10.1038/s41569-021-00646-w
- The paper
- Frangogiannis, N. G. (2022). Transforming growth factor-β in myocardial disease. Nature Reviews Cardiology. https://doi.org/10.1038/s41569-021-00646-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.